You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high-risk CNS tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rare CNS Tumors Outcomes &Risk

Recruiting
  • High Grade Meningioma
  • +4 more
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jul 6, 2022

    Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

    Recruiting
    • Neuroblastoma
    • +2 more
    • Columbus, Ohio
      Nationwide Children's Hospital
    Dec 20, 2022

    Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

    Recruiting
    • Ewing's Family Tumors
    • +11 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Apr 11, 2022

    Glioblastoma, Astrocytoma, Pineoblastoma Trial in Chicago (Stem Cell Transplant)

    Completed
    • Glioblastoma
    • +4 more
    • Stem Cell Transplant
    • Chicago, Illinois
      Children's Memorial Hospital
    Aug 3, 2020

    Non-hodgkin Lymphoma, B Cell Trial in Switzerland (ctDNA detection)

    Not yet recruiting
    • Non-hodgkin Lymphoma, B Cell
    • ctDNA detection
    • Aarau, Switzerland
    • +12 more
    Oct 18, 2023

    CNS Tumors, Pediatric Cancer, GEN1 Gene Mutation Trial in Brno, Prague (FoundationOneHeme)

    Recruiting
    • Central Nervous System Neoplasms
    • +3 more
    • FoundationOneHeme
    • Brno, Czechia
    • +1 more
    Apr 23, 2021

    CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

    Not yet recruiting
    • Central Nervous System Neoplasms
    • +6 more
    • B7-H3-CAR T cells
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Apr 18, 2023

    CNS Tumor, Solid Tumor Trial in Worldwide (Nivolumab and Entinostat)

    Recruiting
    • CNS Tumor
    • Solid Tumor
    • Nivolumab and Entinostat
    • Randwick, New South Wales, Australia
    • +13 more
    Nov 8, 2022

    Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

    Completed
    • Pancreatic Neuroendocrine Tumor G2
    • Octreotide LAR
    • (no location specified)
    Oct 17, 2023

    Right-sided Hemicolectomy for Chldren With High-risk

    Recruiting
    • Neoplasms
    • Appendix Cancer
      • Amsterdam-Zuidoost, Netherlands
        Amsterdam UMC
      Jun 23, 2023

      Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

      Not yet recruiting
      • Anaplastic Astrocytoma
      • +17 more
        • (no location specified)
        Jun 28, 2023

        Lymphocytes, Tumor-Infiltrating Trial in Saint Petersburg (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide,

        Not yet recruiting
        • Lymphocytes
        • Tumor-Infiltrating
        • Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2
        • Saint Petersburg, Florida
        • +1 more
        Sep 15, 2023

        High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

        Recruiting
        • High Grade Glioma
        • +12 more
        • LUTATHERA® (Lutetium Lu 177 dotatate)
        • Aurora, Colorado
        • +8 more
        Jan 16, 2023

        Clinical Research of Drug Holiday Based on MRD Detection in GIST

        Recruiting
        • Gastrointestinal Stromal Tumors
          • Beijing, Beijing, China
            Peking University People's Hospital
          May 11, 2023

          Advanced Solid Tumor, Recurrent Glioma, CNS Lymphoma Trial in United States (PRT811)

          Active, not recruiting
          • Advanced Solid Tumor
          • Recurrent Glioma
          • Denver, Colorado
          • +9 more
          Dec 16, 2022

          Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

          Active, not recruiting
          Has Results
          • Brain and Central Nervous System Tumors
          • Induction Chemotherapy
          • +3 more
          • Palo Alto, California
          • +5 more
          Nov 29, 2022

          Solid Tumor Trial in Washington (Tumor-associated antigen-specific T cell (TAA-T))

          Recruiting
          • Solid Tumor
          • Tumor-associated antigen-specific T cell (TAA-T)
          • Washington, District of Columbia
            Children's National Hospital
          Oct 24, 2022

          Solid Tumors, Brain Tumors Trial in Cincinnati (Amifostine)

          Terminated
          Has Results
          • Solid Tumors
          • Brain Tumors
          • Cincinnati, Ohio
            Cincinnati Children's Hospital Medical Center
          Dec 29, 2021

          Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

          Recruiting
          • Gastrointestinal Stromal Tumors
          • Minimal Residual Disease
          • liquid biopsy
          • Beijing, Beijing, China
            Peking University People'S Hospital
          Sep 18, 2022

          Malignant Solid Tumor Trial in Nashville (Ifetroban Sodium, Placebo)

          Recruiting
          • Malignant Solid Tumor
          • Ifetroban Sodium
          • Placebo
          • Nashville, Tennessee
            Vanderbilt-Ingram Cancer Center
          Jun 23, 2022

          Gastrointestinal Stromal Tumors Trial (Imatinib Mesylate)

          Recruiting
          • Gastrointestinal Stromal Tumors
          • Imatinib Mesylate
          • Seoul, Korea, Republic of
            Asan Medical Center, University of Ulsan College of Medicine
          Dec 22, 2022

          Medulloblastoma, CNS Embryonal Tumors Trial in Canada, New Zealand, United States (Induction, Single Cycle Intensive

          Recruiting
          • Medulloblastoma
          • Central Nervous System Embryonal Tumors
          • Birmingham, Alabama
          • +61 more
          Feb 16, 2022

          Oocyte Freezing for Fertility Preservation in Benign Ovarian

          Recruiting
          • Endometriosis
          • +2 more
            • Lille, France
              Hop Jeanne de Flandre Chu Lille
            Dec 13, 2022

            Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)

            Recruiting
            • Neuroblastoma
            • +5 more
            • GD2-CART01
            • Roma, Italy
              Ospedale Pediatrico Bambino Gesù
            Mar 9, 2022

            Diffuse Large B Cell Lymphoma, CNS Lymphoma Trial in Beijing (Methotrexate)

            Recruiting
            • Diffuse Large B Cell Lymphoma
            • Central Nervous System Lymphoma
            • Beijing, Beijing, China
              Peking union medical college hospital
            Sep 21, 2021